NDC 71288-168

Cytarabine

Cytarabine

Cytarabine is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Cytarabine.

Product ID71288-168_038a9b4b-a951-4c8c-be74-00a4a64eedd1
NDC71288-168
Product TypeHuman Prescription Drug
Proprietary NameCytarabine
Generic NameCytarabine
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2017-11-09
Marketing CategoryANDA /
Application NumberANDA206190
Labeler NameMeitheal Pharmaceuticals Inc.
Substance NameCYTARABINE
Active Ingredient Strength20 mg/mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71288-168-50

1 VIAL, MULTI-DOSE in 1 CARTON (71288-168-50) > 50 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2017-11-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cytarabine" or generic name "Cytarabine"

NDCBrand NameGeneric Name
61703-303CYTARABINECYTARABINE
61703-304CytarabineCYTARABINE
61703-305CytarabineCYTARABINE
61703-319CytarabineCYTARABINE
63323-120CytarabineCYTARABINE
67457-452CytarabineCytarabine
67457-454CytarabineCytarabine
67457-455cytarabinecytarabine
68083-337CytarabineCytarabine
68083-343CytarabineCytarabine
71288-108CytarabineCytarabine
71288-109CytarabineCytarabine
71288-168CytarabineCytarabine
71288-169CytarabineCytarabine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.